Aptevo Therapeutics Inc. (APVO)

NASDAQ: APVO · IEX Real-Time Price · USD

0.713

-0.055 (-7.23%)

At close: Apr 17, 2024, 4:00 PM

0.730

+0.017 (2.44%)

Pre-market: Apr 18, 2024, 8:34 AM EDT

Aptevo Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Cash & Equivalents	16.9	22.64	46.3	42.53	12.45	30.64	7.5	10.08	4.64	3.59
Short-Term Investments	0	0	0	0	0	0	73.69	44.85	0	0
Cash & Cash Equivalents	16.9	22.64	46.3	42.53	12.45	30.64	81.18	54.93	4.64	3.59
Cash Growth	-25.32%	-51.12%	8.86%	241.69%	-59.37%	-62.26%	47.81%	1084.49%	29.06%	-
Receivables	0	2.5	3.66	2.37	0	5.22	2.14	0.31	6.46	13.82
Inventory	0	0	0	0	0	1.79	1.03	0.46	20.32	17.63
Other Current Assets	2.16	2.32	2.6	2.36	17.55	11.05	10.73	15.72	3.72	6.51
Total Current Assets	19.07	27.45	52.57	47.26	30	48.69	95.08	71.41	35.13	41.55
Property, Plant & Equipment	5.78	6.77	3.96	5.54	7.69	5.2	5.84	5.91	4.18	3.2
Long-Term Investments	0	0	0	0	7.5	7.45	10	0	0	0
Goodwill and Intangibles	0	0	0	0	0	5.25	6.08	6.91	46.65	25.12
Other Long-Term Assets	0	0	0.07	0.75	8.22	0.91	0	7.62	41.8	50.1
Total Long-Term Assets	5.78	6.77	4.03	6.28	23.41	18.81	21.92	20.44	92.63	78.42
Total Assets	24.84	34.22	56.6	53.55	53.41	67.49	117.01	91.86	127.77	119.97
Accounts Payable	3.98	3.5	3.46	5.58	6.43	11.67	7.35	10.52	10.08	11.47
Deferred Revenue	0	0	0	0	0	0	0	3.71	7.16	4.54
Current Debt	0	2	11.67	5	19.86	0	3.33	0	0	0
Other Current Liabilities	3.24	3.21	19.63	3.96	11.95	5.94	7.83	5.32	2.7	3.82
Total Current Liabilities	7.22	8.71	34.76	14.54	38.24	17.61	18.51	19.54	19.94	19.84
Long-Term Debt	5.4	7.54	5.05	22.41	3.33	19.28	15.73	18.38	0	0
Other Long-Term Liabilities	0	0	15.58	0	0	0.2	0.73	3.37	19.21	5.53
Total Long-Term Liabilities	5.4	7.54	20.63	22.41	3.33	19.48	16.46	21.75	19.21	5.53
Total Liabilities	12.62	16.24	55.39	36.95	41.57	37.09	34.97	41.29	39.15	25.36
Total Debt	5.4	9.54	16.72	27.41	23.19	19.28	19.06	18.38	0	0
Debt Growth	-43.40%	-42.96%	-39.03%	18.21%	20.29%	1.14%	3.69%	-	-	-
Retained Earnings	-223.45	-206.04	-214.06	-185.61	-167.86	-127.41	-73.72	-80.69	-231.99	-172.67
Comprehensive Income	0	0	0	0	0	0	-0.11	-0.03	0	0
Shareholders' Equity	12.22	17.97	1.22	16.59	11.84	30.41	82.04	50.57	88.62	94.61
Net Cash / Debt	11.51	13.1	29.59	15.12	-10.74	11.36	62.12	36.54	4.64	3.59
Net Cash / Debt Growth	-12.16%	-55.73%	95.69%	-	-	-81.72%	70.00%	688.05%	29.06%	-
Net Cash Per Share	41.38	112.96	277.71	196.20	-162.03	310.93	1793.62	1112.19	141.20	-
Working Capital	11.84	18.74	17.81	32.73	-8.24	31.08	76.57	51.87	15.19	21.72
Book Value Per Share	43.95	155.06	11.41	215.32	178.62	832.45	2368.56	1539.03	2698.42	-

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).